Atul (500027) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
25 Aug, 2025Executive summary
Unaudited standalone and consolidated financial results for Q1 FY25 were reviewed and approved by the Board on July 19, 2024.
Both standalone and consolidated results show year-over-year and sequential growth in revenue and profitability.
Financial highlights
Standalone revenue from operations for Q1 FY25 was ₹1,207.51 cr, up from ₹1,111.52 cr in Q4 FY24 and ₹1,030.24 cr in Q1 FY24.
Standalone net profit for Q1 FY25 was ₹109.18 cr, compared to ₹74.90 cr in Q4 FY24 and ₹96.58 cr in Q1 FY24.
Consolidated revenue from operations for Q1 FY25 was ₹1,322.05 cr, up from ₹1,212.15 cr in Q4 FY24 and ₹1,182.02 cr in Q1 FY24.
Consolidated net profit for Q1 FY25 was ₹112.07 cr, compared to ₹58.79 cr in Q4 FY24 and ₹102.05 cr in Q1 FY24.
Basic and diluted EPS (consolidated) for Q1 FY25 stood at ₹38.00, up from ₹19.81 in Q4 FY24 and ₹35.02 in Q1 FY24.
Outlook and guidance
No explicit forward-looking guidance provided, but sequential and year-over-year growth in key metrics indicates positive momentum.
Latest events from Atul
- Q3 FY26 consolidated net profit rose to ₹163.54 crore on revenue of ₹1,573.62 crore.500027
Q3 25/2623 Jan 2026 - Strong revenue and profit growth in H1 FY2025, led by core chemical segments.500027
Q2 25/2617 Oct 2025 - Q2 FY25 saw strong revenue and profit growth, led by chemicals segments and robust margins.500027
Q2 24/2525 Aug 2025 - Q3 FY25 saw higher revenue and profit year-over-year, with robust segment performance.500027
Q3 24/2525 Aug 2025 - Revenue and profit rose, dividend of ₹25/share proposed, and new Secretarial Auditors appointed.500027
Q4 24/2525 Aug 2025 - Consolidated revenue and profit rose year-over-year, led by strong chemical segment growth.500027
Q1 25/2625 Aug 2025